Don't Go There: A Geospatial mHealth App for Gambling Disorder
Launched by ST. LOUIS UNIVERSITY · Nov 7, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a new mobile health app designed to help people with gambling disorder. The app uses your smartphone's GPS to know your location and sends alerts if you're getting close to a gambling venue. The goal is to see if this app can help individuals manage their gambling habits over a 12-week period.
To participate in the study, you need to be between 18 and 74 years old, speak English, and own an Android phone. You should also have been diagnosed with gambling disorder and have gambled at least four times in the last two months, wagering a total of at least $100. If you join the study, you will be randomly assigned to use the app or not, and your experience will be monitored to see how it affects your gambling behavior. This trial is currently recruiting participants, so if you or someone you know fits the criteria and is interested in helping with this important research, please consider getting involved!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Currently meets DSM-5 criteria for gambling disorder
- • At least 4 non-online gambling episodes in past 60 days
- • Wagering at least $100 total over past 60 days
- • Willingness to accept random assignment
- • English speaking
- • Android phone user
- Exclusion Criteria:
- • Age \<18 years old
- • Severely disruptive behavior
- • Serious uncontrolled psychiatric behavior that requires acute psychiatric care
- • Decline permission to collect zero permission data from smartphone.
About St. Louis University
Saint Louis University (SLU) is a prestigious research institution dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong commitment to ethical research practices and collaboration across interdisciplinary teams, SLU conducts a wide range of clinical studies aimed at addressing critical health challenges. The university leverages its state-of-the-art facilities and expert faculty to facilitate groundbreaking research, ensuring that findings contribute to the development of effective therapies and enhance the overall health of diverse populations. Through its focus on community engagement and translational science, SLU fosters an environment where research translates into tangible benefits for patients and society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Louis, Missouri, United States
Patients applied
Trial Officials
Jeremiah Weinstock, PhD
Principal Investigator
St. Louis University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials